Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Successful omalizumab treatment in chronic spontaneous urticaria is associated with lowering of serum IL-31 levels.

Literature DB >> 25371135

Successful omalizumab treatment in chronic spontaneous urticaria is associated with lowering of serum IL-31 levels.

S Altrichter¹, T Hawro¹, K Hänel^2,3, K Czaja², B Lüscher³, M Maurer¹, M K Church¹, J M Baron².

Abstract

Entities: Chemical Disease Gene

Mesh：

Substances：

Year: 2014 PMID： 25371135 DOI： 10.1111/jdv.12831

Source DB: PubMed Journal: J Eur Acad Dermatol Venereol ISSN： 0926-9959 Impact factor: 6.166

Keyword Cloud
Cited

× No keyword cloud information.

10 in total

1. Interleukin 33 and interleukin 4 regulate interleukin 31 gene expression and secretion from human laboratory of allergic diseases 2 mast cells stimulated by substance P and/or immunoglobulin E.

Authors: Anastasia I Petra; Irene Tsilioni; Alexandra Taracanova; Alexandra Katsarou-Katsari; Theoharis C Theoharides
Journal: Allergy Asthma Proc Date: 2018-03-01 Impact factor: 2.587

2. New insights into the utility of omalizumab.

Authors: Juan Carlos Cardet; Thomas B Casale
Journal: J Allergy Clin Immunol Date: 2019-01-26 Impact factor: 10.793

Review 3. IL-31: State of the Art for an Inflammation-Oriented Interleukin.

Authors: Francesco Borgia; Paolo Custurone; Federica Li Pomi; Raffaele Cordiano; Clara Alessandrello; Sebastiano Gangemi
Journal: Int J Mol Sci Date: 2022-06-10 Impact factor: 6.208

4. Increased serum IL-31 levels in chronic spontaneous urticaria and psoriasis with pruritic symptoms.

Authors: Suteeraporn Chaowattanapanit; Charoen Choonhakarn; Kanin Salao; Kengkart Winaikosol; Narachai Julanon; Rachot Wongjirattikarn; Chingching Foocharoen; Mongkhon Sompornrattanaphan
Journal: Heliyon Date: 2020-12-01

5. Interleukin-31, a Potent Pruritus-Inducing Cytokine and Its Role in Inflammatory Disease and in the Tumor Microenvironment.

Authors: Alain H Rook; Kathryn A Rook; Daniel J Lewis
Journal: Adv Exp Med Biol Date: 2021 Impact factor: 2.622

Successful omalizumab treatment in chronic spontaneous urticaria is associated with lowering of serum IL-31 levels.

1. Interleukin 33 and interleukin 4 regulate interleukin 31 gene expression and secretion from human laboratory of allergic diseases 2 mast cells stimulated by substance P and/or immunoglobulin E.

2. New insights into the utility of omalizumab.

Review 3. IL-31: State of the Art for an Inflammation-Oriented Interleukin.

4. Increased serum IL-31 levels in chronic spontaneous urticaria and psoriasis with pruritic symptoms.

5. Interleukin-31, a Potent Pruritus-Inducing Cytokine and Its Role in Inflammatory Disease and in the Tumor Microenvironment.

6. Increased plasma IL-17, IL-31, and IL-33 levels in chronic spontaneous urticaria.

Review 7. Role of the Pruritic Cytokine IL-31 in Autoimmune Skin Diseases.

8. Biomarkers In Chronic Spontaneous Urticaria: Current Targets And Clinical Implications.

Review 9. Immunological signature of chronic spontaneous urticaria (Review).

Review 10. IL-33/IL-31 Axis: A Potential Inflammatory Pathway.